Literature DB >> 8025431

Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?

A D Struthers1.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8025431      PMCID： PMC2540431          DOI： 10.1136/bmj.308.6944.1615

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

Review 1.  Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides.

Authors:  K Nakao; Y Ogawa; S Suga; H Imura
Journal:  J Hypertens       Date:  1992-09       Impact factor: 4.844

2.  Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

Authors:  C C Lang; A M Choy; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-11       Impact factor: 6.124

3.  Endopeptidase-24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension.

Authors:  M R Wilkins; R J Unwin; A J Kenny
Journal:  Kidney Int       Date:  1993-02       Impact factor: 10.612

4.  Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy.

Authors:  M Yoshibayashi; T Kamiya; Y Saito; H Matsuo
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

5.  Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

Authors:  J G Motwani; H McAlpine; N Kennedy; A D Struthers
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

6.  Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris.

Authors:  H Tanaka; H Yasue; M Yoshimura; E Morita; M Jougasaki; H Kato; Y Miyao; K Nakao
Journal:  Am J Cardiol       Date:  1993-07-15       Impact factor: 2.778

7.  Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.

Authors:  A Lerman; R J Gibbons; R J Rodeheffer; K R Bailey; L J McKinley; D M Heublein; J C Burnett
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

8.  Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.

Authors:  R Pacher; S Globits; J Bergler-Klein; H Teufelsbauer; M Wutte; W Baumgartner; E Ogris; D Glogar
Journal:  Eur Heart J       Date:  1993-02       Impact factor: 29.983

9.  Echocardiography in chronic heart failure in the community.

Authors:  N M Wheeldon; T M MacDonald; C J Flucker; A D McKendrick; D G McDevitt; A D Struthers
Journal:  Q J Med       Date:  1993-01

10.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

Authors:  F Cambien; O Poirier; L Lecerf; A Evans; J P Cambou; D Arveiler; G Luc; J M Bard; L Bara; S Ricard
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962
View more
  10 in total

Review 1.  Postinfarction left ventricular remodelling: where are the theories and trials leading us?

Authors:  Z R Yousef; S R Redwood; M S Marber
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

2.  Acute heart failure: new diagnostic perspectives for the emergency physician.

Authors:  Gino Soldati; Luna Gargani; Fernando R Silva
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

3.  Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study.

Authors:  H Smith; R M Pickering; A Struthers; I Simpson; D Mant
Journal:  BMJ       Date:  2000-04-01

Review 4.  Neuroendocrine changes in chronic cardiac failure.

Authors:  D P Nicholls; G N Onuoha; G McDowell; J S Elborn; M S Riley; A M Nugent; I C Steele; C Shaw; K D Buchanan
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

5.  Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice.

Authors:  D R Murdoch; J Byrne; J J Morton; T A McDonagh; S D Robb; S Clements; I Ford; J J McMurray; H J Dargie
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

6.  Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.

Authors:  T Omland; A Aakvaag; H Vik-Mo
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

7.  Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.

Authors:  Xue-Biao Wei; Lei Jiang; Xin-Rong Liu; Dan-Qing Yu; Ning Tan; Ji-Yan Chen; Ying-Ling Zhou; Peng-Cheng He; Yuan-Hui Liu
Journal:  Eur J Clin Pharmacol       Date:  2016-10-01       Impact factor: 2.953

8.  Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour.

Authors:  J Salzmann; D Flitcroft; C Bunce; D Gordon; R Wormald; C Migdal
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

9.  Predictors of mortality in cardiac surgery: brain natriuretic peptide type B.

Authors:  Jamil Alli Murad Junior; Marcelo Arruda Nakazone; Mauricio de Nassau Machado; Moacir Fernandes de Godoy
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Mar-Apr

Review 10.  New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction.

Authors:  Carsten Tschöpe; Sophie Van Linthout
Journal:  Curr Heart Fail Rep       Date:  2014-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.